Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A team of medical research and statistical modelling experts at Oxford University and the Alan Turing Institute have conducted a joint analysis to assess the impact of the NHS COVID-19 contact tracing app.

Phone screen showing the app in use

The research suggests the app stopped between 200,000 and 900,000 infections between 1st October and 31st December 2020, when 1.9 million people were infected with coronavirus in England and Wales.

Christophe Fraser, Professor of Pathogen Dynamics at Oxford University’s Big Data Institute, Nuffield Department of Medicine, explains: 'We used two separate approaches to analyse the impact of the more than 1.5 million notifications sent by the app in 2020, and both showed that between 200,000 and 900,000 infections have been averted. The impact of the app could be increased if more people use it. For each 1% increase in users we estimate the number of cases will drop by between 0.8% and 2.3%.'

The report shows the app was downloaded onto over 21 million phones, out of 33.7 million eligible people with compatible smartphones living in England and Wales. In 2020, the app sent out an average of 4.4 quarantine notifications for each user who shared their positive test result though the app. Most alerts went out in the second half of December when cases were rising rapidly across the UK due to the new B117 variant.

Read the full story on the University of Oxford website.

The story is also featured in the Fraser Group Coronavirus blog.

Similar stories

PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine

Clinical Trials Coronavirus COVID-19 General Research

From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.

Regular meat consumption linked with a wide range of common diseases

Research

Regular meat consumption is associated with a range of diseases that researchers had not previously considered, according to a large, population-level study conducted by a team at the University of Oxford.

New data show vaccines reduce severe COVID-19 in older adults

Coronavirus COVID-19 Research

New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.